-
Uncategorized4 hours agoKey Senate panel backs Trump’s picks for CDC, pandemic preparedness
WASHINGTON — The Senate health committee approved two Trump administration nominees for key health roles Thursday, including the director of the Centers for Disease Control and...
-
Uncategorized5 hours agoJudge denies states’ motion to postpone Medicaid work requirement
BOSTON — In an order issued Thursday, a federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June. The...
-
Uncategorized5 hours ago
Daiichi’s pipeline falls behind rivals as cash flow nears peak: analysts
With Enhertu and Datroway hitting their peak revenue and rivals flowing into the antibody-drug conjugate space, Jefferies cuts expectations for Daiichi Sankyo.
-
Uncategorized5 hours ago
Latigo Reports Positive Phase IIb Data for Non-Opioid Acute Pain Candidate
Researchers from Latigo Biotherapeutics and its clinical partners have reported positive Phase IIb data for its lead pipeline candidate, the non-opioid acute pain treatment LTG-001, which...
-
Uncategorized6 hours ago
J&J secures right to take the helm in up to $925M Sail CAR T pact
As part of the collaboration, Johnson & Johnson will have an exclusive option to acquire Sail Biomedicines for an additional $2.58 billion.
-
Uncategorized6 hours agoEbola outbreak nears milestone, but vaccine is close
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Earlier this week, STAT’s Anil Oza...
-
Uncategorized7 hours ago
Sanofi’s new CEO wants more ‘realistic view’ of Phase 3 go/no-go decisions
Sanofi is going to “look very deeply” at its late-stage pipeline as part of a portfolio prioritization initiative, though new CEO Belén Garijo didn’t commit to...
